New IDSA/AASLD Guidelines for Hepatitis C John Scott, MD, MScAssociate Professor, UW SoMAsst Director, Liver Clinic, Harborview Medical Center Presentation prepared by Maggie Shuhart, MD and John Scott, MD Last UpdatedTreatmentNaive Genotype 1 Four highly potent DAA combination regimens are recommended for patients with genotype 1 infection, although there are differences in the recommended regimens based on the HCV subtype, the presence or absence of baseline NS5A resistanceassociated substitutions (RASs), and the presence or absence of compensatedGhany MG, Strader DB, Thomas DL, Seeff LB;
Hepatitis C Guidance 19 Update American Association For The Study Of Liver Diseases Infectious Diseases Society Of America Recommendations For Testing Managing And Treating Hepatitis C Virus Infection Ghany
